Zentalis Pharmaceuticals, Inc. (ZNTL) › Cash & EquivalentsZentalis Pharmaceuticals, Inc. (ZNTL) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2019: $67.25M2020: $54.95M2021: $59.71M2022: $43.07M2023: $28.04M2024: $33.90M2025: $35.99M$35.99M2019Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$35.99M+6.2%2024$33.90M+20.9%2023$28.04M-34.9%2022$43.07M-27.9%2021$59.71M+8.7%2020$54.95M-18.3%2019$67.25M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share